Clinical

Clinical  ·  Weekly Digest 22 Feb to 28 Feb 2025
First patient dosed in a Phase 3 clinical study of anti-HER2 biparatopic ADC JSKN003 for the treatment of HER2-positive breast cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 27 Feb 2025: First patient dosed in a Phase 3 clinical study of anti-HER2 biparatopic ADC JSKN003 for the treatment of HER2-positive breast cancer Alphamab Oncology and CSPC have initiated […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 22 Feb to 28 Feb 2025
OS Therapies forms subsidiary OS Drug Conjugates and initiates review of strategic options for its tunable ADC & drug conjugates platforms

Weekly Digest – February 2025 Weekly Digest – February 2025 24 Feb 2025: OS Therapies forms subsidiary OS Drug Conjugates and initiates review of strategic options for its tunable ADC & drug conjugates platforms OS Therapies has launched a subsidiary, […]

by Sandhya Ramalingam

Continue Reading